PATENT CLAIM ANALYSIS

Application Number: 16054451
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["424", "464000"]

Abstract:
Disclosed are novel pharmaceutical compositions containing 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinol-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) (eltrombopag olamine) and processes for preparing the same.

Claim (Index 8):
A method of treating thrombocytopenia in a human in need thereof which comprises administering to such human a therapeutically effective amount of a pharmaceutical tablet according to  claim 7 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.29032
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12607330', '12607291', '12607284', '12607305', '13272367']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8241557141540692
- 35 USC 102 Novelty (BERT): 0.6163111096298071
- Combined Prediction Score: 0.803371253701643
- Mean Citation Score: 577.546632
- Max Citation Score: 578.9488
- Similarity Product: 517.0789943655014

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test